Literature DB >> 17055164

Are sodium channel blockers useless in peripheral neuropathic pain?

Søren H Sindrup, Troels S Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17055164     DOI： 10.1016/j.pain.2006.09.010

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  6 in total

1.  Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain.

Authors:  Ian R Carroll; Jared W Younger; Sean C Mackey
Journal:  Pain Med       Date:  2010-03-04       Impact factor: 3.750

Review 2.  The Na(V)1.7 sodium channel: from molecule to man.

Authors:  Sulayman D Dib-Hajj; Yang Yang; Joel A Black; Stephen G Waxman
Journal:  Nat Rev Neurosci       Date:  2012-12-12       Impact factor: 34.870

Review 3.  [Ins and outs of neurologic therapy for chronic pain].

Authors:  S Sternberg; F Birklein; A May
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

4.  Multivariate analysis of chronic pain patients undergoing lidocaine infusions: increasing pain severity and advancing age predict likelihood of clinically meaningful analgesia.

Authors:  Ian Carroll; Raymond Gaeta; Sean Mackey
Journal:  Clin J Pain       Date:  2007-10       Impact factor: 3.442

5.  A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.

Authors:  Claire Elizabeth Payne; Adam R Brown; Jonathon W Theile; Alexandre J C Loucif; Aristos J Alexandrou; Mathew D Fuller; John H Mahoney; Brett M Antonio; Aaron C Gerlach; David M Printzenhoff; Rebecca L Prime; Gillian Stockbridge; Anthony J Kirkup; Anthony W Bannon; Steve England; Mark L Chapman; Sharan Bagal; Rosemarie Roeloffs; Uma Anand; Praveen Anand; Peter J Bungay; Mark Kemp; Richard P Butt; Edward B Stevens
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

Review 6.  Ion channel pharmacology.

Authors:  Diana Conte Camerino; Domenico Tricarico; Jean-François Desaphy
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.